Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Murphy

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Vaccine|March 22, 2002
The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeysMario H Skiadopoulos, Joanne M Tatem, Sonja R Surman, et al.
The Journal of Infectious Diseases|January 7, 2011
Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemicAnna P Durbin, Alexander Schmidt, Dan Elwood, et al.
Journal of Virology|June 6, 2008
Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epitheliumEmmalene J Bartlett, Margaret Hennessey, Mario H Skiadopoulos, et al.
Virology|November 23, 2005
Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunityMario H Skiadopoulos, Stéphane Biacchesi, Ursula J Buchholz, et al.
Journal of Virology|October 18, 2005
Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primatesAlexander Bukreyev, Zhuhui Huang, Lijuan Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2007
Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogensJoshua M DiNapoli, Alexander Kotelkin, Lijuan Yang, et al.
Virology|July 3, 2010
The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genomeAmber R Engel, Alexander A Rumyantsev, Olga A Maximova, et al.
Plos One|February 8, 2014
Rapid life-history diversification of an introduced fish species across a localized thermal gradientFengyue Zhu, Andrew L Rypel, Brian R Murphy, et al.
Vaccine|July 1, 2008
Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeysJoseph E Blaney, James Speicher, Christopher T Hanson, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|April 9, 2005
Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectorsKathryn A Hanley, Laura B Goddard, Lara E Gilmore, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Vaccine|March 22, 2002
The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeysMario H Skiadopoulos, Joanne M Tatem, Sonja R Surman, et al.
The Journal of Infectious Diseases|January 7, 2011
Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemicAnna P Durbin, Alexander Schmidt, Dan Elwood, et al.
Journal of Virology|June 6, 2008
Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epitheliumEmmalene J Bartlett, Margaret Hennessey, Mario H Skiadopoulos, et al.
Virology|November 23, 2005
Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunityMario H Skiadopoulos, Stéphane Biacchesi, Ursula J Buchholz, et al.
Journal of Virology|October 18, 2005
Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primatesAlexander Bukreyev, Zhuhui Huang, Lijuan Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2007
Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogensJoshua M DiNapoli, Alexander Kotelkin, Lijuan Yang, et al.
Virology|July 3, 2010
The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genomeAmber R Engel, Alexander A Rumyantsev, Olga A Maximova, et al.
Plos One|February 8, 2014
Rapid life-history diversification of an introduced fish species across a localized thermal gradientFengyue Zhu, Andrew L Rypel, Brian R Murphy, et al.
Vaccine|July 1, 2008
Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeysJoseph E Blaney, James Speicher, Christopher T Hanson, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|April 9, 2005
Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectorsKathryn A Hanley, Laura B Goddard, Lara E Gilmore, et al.
Pageof 13